Clik here to view.
欧州麻酔・集中治療学会（ESAIC）が非侵襲的・連続的ヘモグロビンモニタリングを推奨
スイス・ヌーシャテル （ビジネスワイヤ） — マシモ（NASDAQ: MASI）は本日、欧州麻酔・集中治療学会（ESAIC）が発表した最新のガイドラインで、医師による周術期の出血管理を支える上で、非侵襲的・連続的ヘモグロビン（Hb）モニタリングが持つ価値が強調されていると発表しました。ガイドラインは、Masimo...
View ArticleClik here to view.
RWS Supports Project to Renovate and Modernize the Operating Theatre at The...
CHALFONT ST PETER, England RWS, a unique, world-leading provider of technology-enabled language, content and intellectual property services, is proud to partner with The Christian Hospital in...
View ArticleClik here to view.
Cellusion Announces First Patient Transplanted iPSC-Derived Corneal...
TOKYO Cellusion Inc. (CEO: Shin Hatou, M.D. Ph.D., “Cellusion”) announced that our research collaborator, Dr. Shigeto Shimmura, Professor of Fujita Health University and Keio University presented at...
View ArticleClik here to view.
Clik here to view.
中东地区首届全球机器人医疗技术论坛将揭示机器人手术领域的最新进展
阿联酋迪拜 (美国商业资讯)–美国机器人外科学会和Crescent Healthcare（Crescent集团的一个事业部）于2023年3月16日在迪拜举办中东地区首届全球机器人医疗技术论坛(Global Robotic MedTech...
View ArticleClik here to view.
欧洲麻醉学和重症监护学会(ESAIC)推荐无创连续血红蛋白监测
瑞士纳沙泰尔 (美国商业资讯)–Masimo (NASDAQ: MASI)今天宣布，欧洲麻醉学和重症监护学会(ESAIC)发布的最新指南强调了无创的连续血红蛋白(Hb)监测在指导临床医生管理围手术期出血方面的价值。该指南参考了采用Masimo SpHb®等技术的临床研究，指出“使用无创Hb监测方法可能是一种连续监测Hb浓度且不会造成额外累积失血的实用方法。”1...
View ArticleClik here to view.
HPO, in Collaboration with Eastman, Announces Upcoming Launch of High Energy...
CHARLOTTE, N.C. Eastman and High Performance Optics, Inc. (HPO) announced today that a selective High Energy Visible Light (HEVL) filtering window film for the transportation industry will be...
View ArticleClik here to view.
欧州麻酔・集中治療学会（ESAIC）が非侵襲的・連続的ヘモグロビンモニタリングを推奨
スイス・ヌーシャテル （ビジネスワイヤ） — マシモ（NASDAQ: MASI）は本日、欧州麻酔・集中治療学会（ESAIC）が発表した最新のガイドラインで、医師による周術期の出血管理を支える上で、非侵襲的・連続的ヘモグロビン（Hb）モニタリングが持つ価値が強調されていると発表しました。ガイドラインは、Masimo...
View ArticleClik here to view.
RWS Supports Project to Renovate and Modernize the Operating Theatre at The...
CHALFONT ST PETER, England RWS, a unique, world-leading provider of technology-enabled language, content and intellectual property services, is proud to partner with The Christian Hospital in...
View ArticleClik here to view.
Cellusion Announces First Patient Transplanted iPSC-Derived Corneal...
TOKYO Cellusion Inc. (CEO: Shin Hatou, M.D. Ph.D., “Cellusion”) announced that our research collaborator, Dr. Shigeto Shimmura, Professor of Fujita Health University and Keio University presented at...
View ArticleClik here to view.
PHC株式会社：非黒色腫皮膚がん分野における検査機器の共同開発に向けた実現性検討をNovaScan, Inc.と開始
東京 （ビジネスワイヤ） — PHC株式会社（本社：東京都港区、代表取締役社長：中村 伸朗、以下「PHC」）と、NovaScan, Inc.（本社：イリノイ州・シカゴ、CEO：Craig Davis、以下「NovaScan」）は、このたび、病理診断領域の非黒色腫皮膚がん分野における生体外検査機器「MarginScanTM」の共同開発に向けて、実現性検討を開始しましたので、お知らせします。...
View ArticleClik here to view.
PHC Corporation and NovaScan, Inc. Launch Collaboration to Explore the...
TOKYO PHC Corporation (headquarters: Minato-ku, Tokyo, President: Nobuaki Nakamura, hereafter PHC) and NovaScan, Inc. (headquarters: Chicago, Illinois, CEO: Craig Davis, hereafter NovaScan) announce...
View ArticleClik here to view.
athenahealth and Smile Foundation Launch Second Mobile Medical Unit in Bengaluru
WATERTOWN, Mass. athenahealth, Inc., a leading provider of network-enabled software and services for medical groups and health systems nationwide, and Smile Foundation today announced the expansion...
View ArticleClik here to view.
ZAP Surgical Receives Regulatory Approval in India for Its First ZAP-X...
SAN CARLOS, Calif. ZAP Surgical Systems, Inc. today announced that the company received regulatory approval in India for its first ZAP-X® Gyroscopic Radiosurgery® platform in the form of a No...
View ArticleClik here to view.
Provation’s Daniel Hamburger Retires and Company Appoints Ankush Kaul President
MINNEAPOLIS Provation, a leading provider of healthcare productivity and workflow automation software solutions, and a wholly-owned operating company of Fortive Corporation (NYSE: FTV), today...
View ArticleClik here to view.
Establishment Labs Begins a New Era in Breast Aesthetics with Launch of Mia...
NEW YORK Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction,...
View ArticleClik here to view.
Bone Biologics Receives Human Research Ethics Committee Approval to Begin...
BURLINGTON, Mass. Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, announces that the Human Research Ethics Committee (HREC) has approved...
View ArticleClik here to view.
Nova Eye Medical Announces U.S. Market Clearance of the iTrack™ Advance...
FREMONT, Calif. Nova Eye Medical Limited (ASX: EYE) (Nova Eye Medical or the Company), a medical technology company committed to advanced ophthalmic treatment technologies and devices, today...
View ArticleClik here to view.
OliX Pharmaceuticals Announces Positive Results from a Phase 2a Trial of...
SUWON, South Korea OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, today announced positive headline results of a phase 2a trial in the treatment of...
View ArticleClik here to view.
President Bill Clinton to Address 10th Annual World Patient Safety, Science...
IRVINE, Calif. President Bill Clinton, Founder and Board Chair, Clinton Foundation, and 42nd President of the United States, will address the Patient Safety Movement Foundation’s (PSMF) 2023 World...
View Article